|
|
|
|
 |
|
SENSEX
|
 |
-207.95
|
-0.86%
|
|
23842.65
|
|
|
|
NIFTY
|
 |
-702.68
|
-0.91%
|
|
76847.57
|
|
|
|
Nasdaq
|
 |
280.85
|
1.23%
|
|
23183.74
|
|
|
|
Nikkei 225
|
 |
-421.34
|
-0.74%
|
|
56502.77
|
|
|
|
FTSE 100
|
 |
-17.50
|
-0.17%
|
|
10583.00
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As on 13-Apr-26
|
|
Aavas Financiers
|
|
|
|
The Exchange has sought clarification from AAVAS Financiers Ltd on April 13, 2026, with reference to news appeared in https://cfo.economictimes.indiatimes.com/dated April 13, 2026, quoting "Aavas Financiers may be headed for leadership change; Kotak's Manu Singh likely to be next CEO."The reply is awaited.
|
|
|
|
|
Addictive Learn Tech
|
|
|
|
Siddhant Singh Baid has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
|
|
|
|
|
Alphalogic Techsys
|
|
|
|
With reference to the email received from the Exchange dated 13th April 2026 seeking clarification on the movement in the price of our security at the exchangein the recent past, please find reply for the same.
|
|
|
|
|
Amiable Logistic (i)
|
|
|
|
Amiable Logistics (India) Limited has informed the Exchange regarding 'Reconciliation of Share Capital Audit Report as per Regulation 76 of the SEBI(Depositories and Participants) Regulations, 2018'.
|
|
|
|
|
Aqylon Nexus
|
|
|
|
Inter alia considered and transacted the following business: 01. The Board of Directors has considered and approved the proposal for incorporation of a Wholly Owned Subsidiary Company (100% ownership) at Ras Al Khaimah Economic Zone Authority, United Arab Emirates (UAE), under the name and style of M/s Aqylon Nexus Holding LLC or such other name as may be approved by the appropriate authorities. The Board has authorized Mr. Kiran Kumar Inampudi [DIN:01024343] Director, to take all necessary steps, as may be required in this connection. This strategic decision follows the overwhelming growth and strong market demand for our AI Technology Products and Services. Encouraged by this positive response and recognizing the United Arab Emirates (UAE) as the next major growth market for our products, the Company has decided to expand its international footprint through this new incorporation in United Arab Emirates (UAE). 2. Mr. Sripal Reddy Molugu [DIN: 03642466] has resigned from the post of Independent Director of Company with effect from 10th April 2026, due to pre-occupancy and other commitments. He has confirmed that there is no material reason for his resignation other than mentioned in his resignation letter. 3. The Board of Directors has acknowledged the receipt of a proposal (?the Proposal?) from M/s Energon Petroproducts Private Limited, expressing their intention to sell their entire shareholding of 33,73,690 equity shares, representing 100% of the share capital. The Board has authorized Mr. Srivatsava Sunkara [DIN: 01725431], Managing Director, to take all necessary actions as may be required in this regard.
|
|
|
|
|
Asian Warehousing
|
|
|
|
Inter alia, has approved the following: a. To enter into a Material Related Party Transaction with Mr. Bhavik Bhimjyani, Chairman and Managing Director of the Company, for availing of loan(s) from him during the financial year 2026?2027, subject to the approval of the shareholders, on such terms and conditions as may be approved by the Board. b. Postal Ballot Notice for approving Material Related Party Transaction with Mr. Bhavik Bhimjyani, Chairman and Managing Director of the Company. c. Appointment of Mr. Hemanshu Upadhyay, Practicing Company Secretary as Scrutinizer for conducting the Postal Ballot?s e-voting process in a fair and transparent manner
|
|
|
|
|
Aspira Pathlab&diagn
|
|
|
|
Aftertrade Broking Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer Advertisement and Corrignendum to the Detailed Public Statementunder Regulation 18(7) in terms of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 to the Public Shareholders of the Aspira Pathlab &Diagnostics Ltd ("Target Company").
|
|
|
|
|
Bafna Pharma
|
|
|
|
The Exchange has sought clarification from Bafna Pharmaceuticals Ltd on April 13, 2026 with reference to significant movement in price, in order to ensure thatinvestors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
|
|
|
|
|
Balaxi Pharma.
|
|
|
|
BALAXI PHARMACEUTICALS LIMITED has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
|
|
|
|
|
Balurghat Tech
|
|
|
|
We are hereby submitting our reply to the query raised by BSE seeking Clarification on Price Movement.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|